# A Relative BioavailabilityStudy Of Ibuprofen 40mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.

> **NCT01466517** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 70 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Alivium®
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT01466517
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2012-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466517, "A Relative BioavailabilityStudy Of Ibuprofen 40mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01466517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*